RTW INVESTMENTS, LP Q2 2021 Filing
Filed August 13, 2021
Portfolio Value
$6.6B
Holdings
113
Report Date
Q2 2021
Filing Type
13F-HR
All Holdings (113 positions)
| Stock | Value |
|---|---|
RCKTROCKET PHARMACEUTICALS INC | $663.9M |
SPYSPDR S&P 500 ETF TR | $426.5M |
ALNYALNYLAM PHARMACEUTICALS INC | $285.4M |
—DICERNA PHARMACEUTICALS INC | $280.7M |
VCELVERICEL CORP | $237.2M |
MRTXEURMIRATI THERAPEUTICS INC | $235.4M |
ILMNILLUMINA INC | $228.5M |
PTCTPTC THERAPEUTICS INC | $223.8M |
ESTAESTABLISHMENT LABS HLDGS INC | $202.6M |
3M4MASIMO CORP | $200.3M |
NTRANATERA INC | $194.4M |
PTGXPROTAGONIST THERAPEUTICS INC | $157.4M |
TXG10X GENOMICS INC | $143.8M |
TCE2CELLDEX THERAPEUTICS INC NEW | $130.7M |
DMTKQDERMTECH INC | $129.6M |
GMEDGLOBUS MED INC | $129.5M |
AXNX*AXONICS INC | $123.3M |
STOKSTOKE THERAPEUTICS INC | $122.7M |
GHGUARDANT HEALTH INC | $114.0M |
QDELUSDQUIDEL CORP | $112.6M |
TNDMTANDEM DIABETES CARE INC | $111.8M |
AXSMAXSOME THERAPEUTICS INC | $109.0M |
RNAAVIDITY BIOSCIENCES INC | $98.7M |
EPIEURESSA PHARMA INC | $87.3M |
CCCCC4 THERAPEUTICS INC | $81.3M |
—PROMETHEUS BIOSCIENCES INC | $76.0M |
IDYAIDEAYA BIOSCIENCES INC | $68.6M |
MGNXMACROGENICS INC | $68.4M |
RGNXREGENXBIO INC | $68.3M |
AGENEURAGENUS INC | $62.8M |
CSTLCASTLE BIOSCIENCES INC | $58.6M |
TARSTARSUS PHARMACEUTICALS INC | $58.4M |
NSTGEURNANOSTRING TECHNOLOGIES INC | $52.1M |
LUNGPULMONX CORP | $49.8M |
RLMDRELMADA THERAPEUTICS INC | $49.2M |
—LANDOS BIOPHARMA INC | $48.5M |
IMCRIMMUNOCORE HLDGS PLC | $47.9M |
5E7ITEOS THERAPEUTICS INC | $44.0M |
PRQRPROQR THRAPEUTICS N V | $43.4M |
—OLINK HLDG AB | $43.0M |
GHRSGH RESEARCH PLC | $42.7M |
OPHTEURIVERIC BIO INC | $42.4M |
CYTKCYTOKINETICS INC | $39.6M |
AVDLAVADEL PHARMACEUTICALS PLC | $38.6M |
OMGBPOUTSET MED INC | $36.8M |
—GENETRON HLDGS LTD | $36.6M |
CUTREURCUTERA INC | $35.3M |
APYXAPYX MEDICAL CORPORATION | $35.0M |
MDXGMIMEDX GROUP INC | $33.8M |
FULCFULCRUM THERAPEUTICS INC | $33.6M |
OYSTOYSTER PT PHARMA INC | $32.0M |
JNJJOHNSON & JOHNSON | $28.1M |
ADVMCHFADVERUM BIOTECHNOLOGIES INC | $25.8M |
GLUEMONTE ROSA THERAPEUTICS INC | $25.2M |
MISTMILESTONE PHARMACEUTICALS IN | $23.7M |
TELATELA BIO INC | $22.4M |
CLSDUSDCLEARSIDE BIOMEDICAL INC | $20.5M |
TREURTRILLIUM THERAPEUTICS INC | $20.3M |
—ATHIRA PHARMA INC | $19.5M |
I9DNARBUTUS BIOPHARMA CORP | $18.1M |
PMVPPMV PHARMACEUTICALS INC | $16.5M |
BWAYBRAINSWAY LTD | $16.3M |
BLUBELLUS HEALTH INC NEW | $15.4M |
NEONEOGENOMICS INC | $13.1M |
CERE1EURCEREVEL THERAPEUTICS HLDNG I | $12.8M |
XGNEXAGEN INC | $12.3M |
BMEABIOMEA FUSION INC | $12.3M |
INMDINMODE LTD | $11.8M |
BLIUSDBERKELEY LTS INC | $11.5M |
IMUXIMMUNIC INC | $11.3M |
—ASLAN PHARMACEUTICALS LTD | $10.7M |
NAUTNAUTILUS BIOTECHNOLOGY INC | $10.4M |
—LA JOLLA PHARMACEUTICAL CO | $10.0M |
—LIFESCI ACQUISITION II CORP | $9.8M |
—VINCERX PHARMA INC | $9.7M |
ARGXARGENX SE | $9.6M |
CTMXCYTOMX THERAPEUTICS INC | $8.9M |
CNTBCONNECT BIOPHARMA HLDGS LTD | $8.8M |
—CHARDAN HEALTHCR ACQSTN 2 CO | $8.3M |
MLTXHELIX ACQUISITION CORP | $7.8M |
AFIBACUTUS MED INC | $7.7M |
—BCTG ACQUISITION CORP | $6.8M |
—RESEARCH ALLIANCE CORP II | $6.5M |
—BCLS ACQUISITION CORP | $6.5M |
—ITAMAR MED LTD | $6.3M |
APVOAPTEVO THERAPEUTICS INC | $6.3M |
RCELAVITA MEDICAL INC | $5.7M |
—ARYA SCIENCES ACQU CORP IV | $5.4M |
—THERAPEUTICS ACQUISITION COR | $5.0M |
—SUMMIT HEALTHCRE ACQUISTN CO | $5.0M |
SRRKSCHOLAR ROCK HLDG CORP | $4.7M |
DNAYCODEX DNA INC | $4.4M |
CVRXCVRX INC | $4.2M |
IMTXIMMATICS N.V | $4.1M |
—5 01 ACQUISITION CORP | $3.9M |
—CHARDAN HEALTHCR ACQSTN 2 CO | $3.6M |
—MIROMATRIX MED INC | $3.3M |
PSNLPERSONALIS INC | $3.2M |
MRVIMARAVAI LIFESCIENCES HLDGS I | $2.9M |
—MEDICUS SCIENCES ACQUISITION | $2.9M |
Page 1 of 2Next